Literature DB >> 25863778

Long-term follow-up of immunotherapy-unresponsive recurrent tumefactive demyelination.

Delon La Puma1, Sara Llufriu1, Maria Sepúlveda1, Yolanda Blanco1, Teresa Ribalta2, Francesc Graus1, Albert Saiz3.   

Abstract

Entities:  

Keywords:  Chemotherapy; Demyelinating disease; Immunotherapy; MRI; Multiple sclerosis; Tumefactive

Mesh：

Year:  2015        PMID： 25863778     DOI： 10.1016/j.jns.2015.03.038

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  3 in total

1.  Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis.

Authors:  Masataka Nakamura; Kumi Itani; Kousuke Miyake; Takenobu Kunieda; Satoshi Kaneko; Hirofumi Kusaka
Journal:  Intern Med       Date:  2017-01-15       Impact factor: 1.271

2.  Transtentorial herniation from tumefactive multiple sclerosis mimicking primary brain tumor.

Authors:  Kunal Vakharia; Haris Kamal; Gursant S Atwal; James L Budny
Journal:  Surg Neurol Int       Date:  2018-10-17

3.  Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases.

Authors:  Aigli G Vakrakou; Dimitrios Tzanetakos; Maria-Eleptheria Evangelopoulos; Theodore Argyrakos; John S Tzartos; Maria Anagnostouli; Elissavet Andreadou; Georgios Koutsis; Georgios Velonakis; Panagiotis Toulas; Elias Gialafos; Antonios Dimitrakopoulos; Erasmia Psimenou; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Ther Adv Neurol Disord       Date:  2021-05-18       Impact factor: 6.570
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.